The place of dydrogesterone in the treatment of endometriosis and adenomyosis

Maturitas

Volumn 65, Issue SUPPL. 1, 2009, Pages

  Schweppe, Karl Werner ^a  

^a Ammerland Klinik GmbH   (Germany)

Author keywords

Adenomyosis; Bleeding disorders; Dydrogesterone; Endometriosis; Progestins

Indexed keywords

DANAZOL; DIENOGEST; DYDROGESTERONE; MEDROGESTONE; METHYLPREDNISOLONE ACETATE; NORETHISTERONE ACETATE; PLACEBO; PROGESTERONE DERIVATIVE;

ADENOMYOSIS; ARTICLE; BLEEDING; CLINICAL TRIAL; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; DRUG TOLERABILITY; ENDOMETRIOSIS; HUMAN;

DYDROGESTERONE; ENDOMETRIOSIS; FEMALE; HUMANS; PREGNANCY; PROGESTINS; UTERINE HEMORRHAGE;

EID: 72649099987     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.11.011     Document Type: Article

References (50)

1. Hammond C.B., and Haney A.F. Conservative treatment of endometriosis. Fertil Steril 30 (1978) 497-509
2. Cornillie F.J., Puttemans P., and Brosens I.A. Histology and ultrastructure of human endometriotic tissue treated with dydrogesterone (Duphaston). Eur J Obstet Gynecol Reprod Biol 26 (1987) 39-55
3. Kauppila A., Rönnberg L., and Viehko R. Steroidrezeptoren in endometrischem Gewebe. Endometriose 4 (1986) 56-59
4. Vierikko P., Kauppila A., Rönnberg L., and Viehko R. Steroidal regulation of endometriosis tissue. Fertil Steril 43 (1985) 218-223
5. Obolensky W., and Kamber J. Therapie der Endometriose mit Dydrogesteron in Depot form. Ther Umsch 30 (1973) 558-562
6. Schweppe K.W. Klinik und Morphologie der Endometriose (1984), Schattauer, Stuttgart/New York pp. 133-50
7. Zeitoun K.M., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17β-hydroxisteroid dehydrogenase type 2 expression in endometriosis. Failure to metabolize 17β-estradiol. J Clin Endocrinol Metab 83 (1998) 4474-4478
8. Attar E., and Bulun S.E. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Human Reprod Updates 12 (2006) 49-56
9. Horie S., Harada T., Mitsunari M., Taniguchi F., Iwabe T., and Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear kappa-β inactivation in endometriotic stromal cells. Fertil Steril 83 (2005) 1530-1535
10. Ragupathy R., Al Mutawa E., Makhseed M., Azizieh F., and Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 112 (2005) 1096-1101
11. Simoncini T., Caruso A., Giretti M.S., Scorticati C., Fu X.D., Garibaldi S., et al. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril 86 Suppl. 4 (2006) 1235-1242
12. Backer M.H. Isopregnenone (Duphaston): a new progestational agent. Obstet Gynecol 19 (1962) 724-729
13. Aydar C.K., and Greenblatt R.B. 6-Dehydro-retroprogesterone (Duphaston). An interesting progesterone-like compound. Int J Fertil 33 (1964) 585-595
14. Ullery J.C., DeNeef J.C., and Holzaepfel J.H. Dydrogesterone therapy: clinical observations and laboratory findings in 61 patients. Obstet Gynecol 22 (1963) 38-45
15. Chang I.W. Clinical trial of isopregnone, a new progestational agent. Preliminary study. Med Ann Dist Columbia 31 (1962) 402-405
16. Villedieu P., and Mousselon J. A new synthetic progestational hormone, 6-dehydro-retro-progesterone (dydrogesterone). Clinical study. Presse Med 71 (1963) 337-338
17. Johnston W.I.H. Dydrogesterone and endometriosis. BJOG 83 (1976) 77-80
18. Walker S.M. The treatment of endometriosis with dydrogesterone. Br J Clin Pract Suppl. 24 (1983) 40-46
19. Kaiser E., and Wagner ThA. Die Behandlung der Endometriose mit Dydrogesteron. TW Gynaekologie 2 (1989) 386-388
20. Overton C.E., Lindsey P.C., Johal B., Collins S.A., Siddle N.C., Shaw R.W., et al. A randomized double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 62 (1994) 701-707
21. Tumasian K.P., Bespoiasnaia V.V., and Voronovskaia I.V. Treatment of endometriosis in female infertility. Lik Sprava 3 (2001) 103-105
22. Makhmudova G.M., Nazhmutdinova D.K., Gafarova D.Kh., and Lukmanova Yu.D. Efficacy of Duphaston treatment in women who have undergone reconstructive plastic surgery for endometriosis. Akusherstvo I Ginekologiia 4 (2003) 42-46
23. Trivedi P., Selvaraj K., Das Mahapatra P., Srivastava S., and Malik S. Effective post-lapaoscopic treatment of endometriosis with dydrogesterone. Gynecol Endocrinol 23 S1 (2007) 73-76
24. Bishop P.M.F. A new oral progestogen in the treatment of dysmenorrhoea. Proc R Soc Med 9 (1961) 752-754
25. Fairweather D.V.I. Duphaston in dysmenorrhoea. J Obst Gyn Br Comm 72 (1965) 193-195
26. Aydar C.K., and Coleman B.D. Treatment of primary dysmenorrhea. A double blind study. JAMA 192 (1965) 1003-1005
27. Schellen A.A.C.M., and Wesselius de Casparis A. Treatment of dysmenorrhoea with dydrogesterone. Results of a double blind trial. Bull Soc Royale Belge Gynécol Obstét 37 (1967) 273-276
28. Gould C.H.D. Dydrogesterone in the teenage dysmenorrhea. Practitioner 222 (1979) 718-723
29. Ohlenroth G., and Hatzmann W. Die Therapie der juvenilen Dysmenrrhö mit 6-Dehysro-Retro-Progesteron. Med Welt 33 (1982) 645-648
30. Seliger E., Kaltwasser P., Schneider F., Rothe K., and Röpke F. Behandlung der Endometriose mit Dienogest-Einfluss auf den Rezeptorstatus im Endometrium und vergleichende Bindungsstudien. In: Teichmann A.T. (Ed). Dienogest-Präklinik und Klinik eines Gestagens (1995), W. de Gruyter Verlag, Berlin/New York 231-243
31. Telimaa S., Puolakka J., Rönnberg I., and Kauppila A. Placebo controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1 (1987) 13-19
32. Schweppe K.-W. Einsatz der Gestagene zur Behandlung der Endometriose-Medrogeston versus Danazol. In: Schindler A.E., and Ebert Ch (Eds). Menopause Aktuell (1996), Aesopus, Basel 85-93
33. Schlaff W.D., Carson S.A., Luciano A., Ross D., and Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 85 (2006) 314-325
34. Crosignani P.G., Luciano A., Ray A., and Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 21 (2006) 248-256
35. Cheewadhanaraks S., Peeyananjarassri K., Choksuchat C., Dhanaworavibul K., Choobun T., and Bunyapipat S. Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endometriosis-associated pain: a randomized comparative trial. Gynecol Obstet Invest 68 (2009) 116-121
36. Vercellini P., Frontino G., De Giorgi O., Aimi G., Zaina B., and Crosignani P.G. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 80 (2003) 305-309
37. Lockhat F.B., Emembolu J.O., and Konje J.C. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 20 (2005) 789-793
38. Vercellini P., Trespidi L., and Vendola N. A gonadotropin releasing hormone agonist versus a low dose OC for pelvic pain associated with endometriosis. Fertil Steril 60 (1993) 75-79
39. Regidor P.A., Regidor M., Schmidt M., Ruwe B., Lübben G., Förtig P., et al. Prospective randomised study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 14 (2000) 1-8
40. Harada T., Momoeda M., Taketani Y., Aso T., Fukunaga M., Hagino H., et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial. Fertil Steril 91 (2009) 675-681
41. Timmonen S., and Johansson C.J. Endometriosis treated with lynestrenol. Ann Chir Gynaecol 57 (1986) 144-147
42. Selak V., Farquhar C., Prentice A., and Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 4 October (2007) [CD000068]
43. Marshall K., Senior J., and Clayton J. Infertility. Pharm J 256 (1996) 303-307
44. Schweppe K.-W. GnRH analogues: state of the art. In: Lunenfeld B., and Insler V. (Eds). GnRH analogues (1996), Parthenon Publishing Group, New York/Carnforth 83-94
45. Vercellini P., Cortesi I., and Crosignani P.G. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 68 (1997) 393-401
46. Vercellini P., Fedele L., Pietropaplo G., Frontino G., Somigliana E., and Crosignani P.G. Progestogens for endometriosis: forward to the past. Hum Reprod Update 9 (2003) 387-396
47. Prentice A., Deary A.J., and Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2 (2000) [CD002122]
48. Schroder A.K., Diedrich K., and Ludwig M. Medical management of endometriosis: a systemic review. Drugs 7 (2004) 451-463
49. Vercellini P., Somigliana E., Viganò P., Abbiati A., Barbara G., and Crosignani P.G. Endometriosis: current therapies and new pharmacological developments. Drugs 69 (2009) 649-675
50. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 4 (1998) 323-336